RBC Capital analyst Ben Hendrix reiterates Surgery Partners (NASDAQ:SGRY) with a Outperform and m

TD Cowen analyst Ryan Langston reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains

Analysts raised price targets for Meta, IREN, Coinbase, Roblox and others; IREN and Coinbase were up

JP Morgan analyst Benjamin Rossi maintains Surgery Partners (NASDAQ:SGRY) with a Neutral and rais

TD Cowen analyst Ryan Langston maintains Surgery Partners (NASDAQ:SGRY) with a Buy and raises the

RBC Capital analyst Ben Hendrix maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lo

Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight

Surgery Partners (NASDAQ:SGRY) reported quarterly earnings of $0.10 per share which beat the analyst

Surgery Partners (NASDAQ:SGRY) affirms FY2026 sales outlook from $3.350 billion-$3.450 billion to $3

Surgery Partners rises after agreeing to sell Idaho Falls hospital stakes for $795 million while rea

Surgery Partners (NASDAQ:SGRY) affirms FY2026 sales outlook from $3.350 billion-$3.450 billion to $3

Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leadin

2026 GuidanceFull year 2026 revenue guidance reaffirmed to be in the range of $3.35 billion to $3.45

Surgery Partners (NASDAQ:SGRY) reported quarterly losses of $(0.03) per share which beat the analyst

Surgery Board and Management Team Have Presided Over the Vast Destruction of Value and Must Be Held

TD Cowen analyst Ryan Langston maintains Surgery Partners (NASDAQ:SGRY) with a Buy and lowers the

UBS analyst A.J. Rice maintains Surgery Partners (NASDAQ:SGRY) with a Buy and lowers the price ta

Mizuho analyst Ann Hynes maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers th

RBC Capital analyst Ben Hendrix maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lo

Barclays analyst Andrew Mok maintains Surgery Partners (NASDAQ:SGRY) with a Equal-Weight and lowe

MDB stock fell 27.2% in pre-market trading after reporting Q4 earnings of $1.65 per share, revenue o

Surgery Partners (NASDAQ: SGRY) shares drop in premarket as company reports lower than expected earn

Shares of Ouster Inc (NASDAQ:OUST) rose sharply in pre-market trading after the company reported bet

Share Repurchase ProgramOn February 26, 2026, the Board of Directors of the Company authorized a new

Surgery Partners (NASDAQ:SGRY) sees FY2026 sales of $3.350 billion-$3.450 billion vs $3.559 billion

Surgery Partners (NASDAQ:SGRY) reported quarterly earnings of $0.12 per share which missed the analy

Mizuho analyst Ann Hynes maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers th

Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leadin

Surgery Partners, Inc. (NASDAQ:SGRY) announces a new partnership with Baylor Scott & White Healt

JP Morgan analyst Benjamin Rossi maintains Surgery Partners (NASDAQ:SGRY) with a Neutral and lowe

Barclays analyst Andrew Mok maintains Surgery Partners (NASDAQ:SGRY) with a Equal-Weight and lowe

Mizuho analyst Ann Hynes maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lowers th

UBS analyst A.J. Rice maintains Surgery Partners (NASDAQ:SGRY) with a Buy and lowers the price ta

RBC Capital analyst Ben Hendrix maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and lo

Benchmark analyst Bill Sutherland maintains Surgery Partners (NASDAQ:SGRY) with a Buy and lowers

Surgery Partners (NASDAQ:SGRY) lowers FY2025 sales outlook from $3.300 billion-$3.450 billion to $3.

Surgery Partners (NASDAQ:SGRY) reported quarterly earnings of $0.13 per share which missed the analy

Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight

JP Morgan analyst Benjamin Rossi assumes Surgery Partners (NASDAQ:SGRY) with a Neutral rating and

Surgery Partners (NASDAQ:SGRY) affirms FY2025 sales outlook from $3.300 billion-$3.450 billion to $3